The fourth person in the world to receive the Total Artificial Heart had it for 15 days before receiving a heart transplant. Mr. Michael Herrmann expressed his gratitude for the technology, saying, "You can't describe how much different it is—I feel normal." Thank you to Mr. Herrmann, his family, and all of the clinicians at The Christ Hospital Health Network - we are thrilled to have your support as we go through our FDA-approved Early Feasibility Studies. https://lnkd.in/eKZKHn55 #innovation #artificialheart #medtech
关于我们
BiVACOR? is a clinical-stage medical device company pioneering the development of a long-term therapy for patients with biventricular heart failure. Under the expert direction of its founder and Total Artificial Heart (TAH) inventor, Daniel Timms, PhD, and the guidance of two luminaries in cardiovascular surgery, William E. Cohn, MD, and O.H. (Bud) Frazier, MD, the BiVACOR TAH is currently undergoing an FDA-approved first-in-human Early Feasibility Study (EFS). Headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international offices in Gold Coast, Australia, BiVACOR is committed to addressing the global unmet need of patients with end-stage heart failure awaiting transplant by providing the next generation of life-extending solutions. About the BiVACOR Total Artificial Heart (TAH): The BiVACOR TAH represents a paradigm shift in artificial heart design. The size of the BiVACOR TAH is suitable for most men and women (Body Surface Area >1.4 m2). Despite its small size, the BiVACOR TAH is capable of providing enough cardiac output for an adult male undergoing exercise. Using magnetic levitation technology, the same principle used in high-speed trains, the product features a unique pump design with a single moving part: a magnetically suspended dual-sided rotor with left and right vanes positioned within two separate pump chambers, forming a double-sided centrifugal impeller that propels blood from the respective pump chambers to the pulmonary (lung) and systemic (body) circulations. The TAH has no valves or flexing ventricle chambers, with MAGLEV making pulsatile outflow possible by rapidly cycling the pump's rotor. The non-contact suspension of the rotor via MAGLEV is designed to eliminate the potential for mechanical wear and provide large blood gaps that minimize blood trauma, offering a durable, reliable, and biocompatible heart replacement.
- 网站
-
https://www.bivacor.com
BiVACOR的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Huntington Beach，California
- 类型
- 私人持股
- 创立
- 2008
- 领域
- Rotary Blood Pumps、Biomedical Engineering、Heart Failure、Total Artificial Heart、Artificial Heart、Heart Transplant和Bridge to Heart Transplant
地点
BiVACOR员工
动态
-
For over two decades, TIME has spotlighted breakthroughs that redefine the future. This year, TIME editors recognized the BiVACOR Total Artificial Heart as a TIME’s 2024 Best Inventions under the Experimental category. Congratulations to the entire BiVACOR team—your vision and dedication continue to push the boundaries of what’s possible! https://lnkd.in/ewMz6fTj #TIMEBestInventions
-
-
Join Daniel Timms this week at the AusBiotech 2024 National Conference, where he has been invited as a keynote speaker to deliver the prestigious Millis Oration. Named in honor of Emeritus Professor Nancy Millis, a pioneer in Australian biotechnology, this keynote is a major highlight of the event. Dr. Timms, Founder and CTO of BiVACOR, has spent over two decades developing the revolutionary BiVACOR titanium heart—a groundbreaking alternative to traditional heart transplants. In his keynote, "The Medical Moonshot—A Decades-Long Quest to Build an Artificial Heart," he will share the journey of creating a total artificial heart and the cutting-edge technology that is bringing his life's work to fruition. ?? Wednesday, 30 October?? ?? 9:30 am https://lnkd.in/grG6PqQK
?? AusBiotech is thrilled to have Dr Daniel Timms, inventor of the world’s first durable artificial heart, as the?Millis Orator at the AusBiotech 2024 National Conference. The?Millis Oration, named in honour of Emeritus Professor Nancy Millis’s pioneering contributions to Australian biotech, is a highlight of the annual conference supported by CSL. As Founder and CTO of BiVACOR, Dr Timms has spent over two decades developing the revolutionary BiVACOR titanium heart—a groundbreaking alternative to heart transplants. In his keynote, The Medical Moonshot—A Decades-Long Quest to Build an Artificial Heart, he’ll discuss?the complexities of creating an artificial heart and how cutting-edge tech is turning this vision into reality. At the heart of Dr Timms's innovation is a story about determination and tenacity. ?? Wednesday 30 October ?? 9:30 am #AusBio24 #AusBiotech2024 #Medtech #ArtificialHeart Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions,
-
-
Congratulations to all those named in The Australian's Top 100 Innovators 2024! We are honored that our founder, Daniel Timms, is among this incredible group of forward-thinking leaders. Their groundbreaking ideas and solutions are shaping the future. #innovation #medical #heartfailure #TotalArtificialHeart
The Australian’s 2024 list of 100 leading innovators ranges across medicine and health to energy, art and design and e-commerce: https://bit.ly/3A2u7C1
-
-
BiVACOR转发了
Dr. "Bud" Frazier's pioneering work on artificial hearts at The Texas Heart Institute has played a crucial role in fostering a major breakthrough that is revolutionizing the treatment of heart failure. Texas Monthly highlights his groundbreaking work leading up to the first implantation of the BiVACOR Total Artificial Heart: https://lnkd.in/gz2_vXjz
-
-
"It wasn't just about me, it was about helping others" - Stephan Crudup, the third patient to be implanted with the BiVACOR Total Artificial Heart as part of the early feasibility study. We are incredibly grateful for Mr. Crudup and his family's support and to Dr. Francisco Arabia and the entire team at Banner Health. Each milestone brings us one step closer to getting the TAH to the many who may need it. “I’m thriving, surviving, and living better than I was with my sick heart,” Crudup said while supported by the BiVACOR TAH for almost a month. Watch his story here: https://lnkd.in/e7w6u7eS
Tempe man with heart failure among handful of people to receive total artificial heart
abc15.com
-
We are deeply honored to have Mr. Harbison share his remarkable journey as the second individual ever to receive the BiVACOR Total Artificial Heart. His courage, along with his family's unwavering support, is instrumental in advancing our progress in the clinic and driving the momentum of this early feasibility study. Watch the story on NBC News: https://lnkd.in/efbaqqdY.
'My heart was gone': Second person to receive a titanium heart shares experience
nbcnews.com
-
Stop Scrolling! Take a second and set yourself a reminder to tune into NBC News Now tonight at 8 p.m. (ET).... https://lnkd.in/dJZG-p4
Watch NBC News NOW: Live TV | NBC News
nbcnews.com
-
"Utilizing advanced maglev technology, our Total Artificial Heart brings us one step closer to providing a desperately needed option for people with end-stage heart failure who require support while waiting for a heart transplant." - Dr. Daniel Timms, Founder & CTO of BiVACOR ?? CyberGuy , Kurt Knutsson https://lnkd.in/ep2fSgVf
Mechanical artificial heart is using high-speed rail tech to keep patients alive
yahoo.com
-
The first patient received the BiVACOR Total Artificial Heart (TAH) implant on July 9 as part of the?U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS). On July 17, eight days following the BiVACOR TAH implant, a donor heart became available and was transplanted into the patient, removing the BiVACOR TAH and meeting a goal of the EFS to evaluate the safety and performance of the BiVACOR TAH as a bridge-to-heart-transplant solution for patients living with severe biventricular heart failure or univentricular heart failure in which left ventricular assist device support is not recommended. The Texas Heart Institute ?? ScienceAlert, Carly Cassella https://lnkd.in/g48-izrc
World First: Heart Made From Titanium Kept a Man Alive For Days
sciencealert.com